Is a
Clinical Study attributes
NCT Number
Trial Recruitment Size
1360
Trial Sponsor
Clinical Trial Start Date
2015
0Primary Completion Date
2017
0Study Completion Date
2017
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Drug0
Intervention Name
Liraglutide0
ITCA 650 Osmotic Mini Pump 60 mcg/day0
ITCA 650 Osmotic Mini Pump 20/60 mcg/day0
Metformin0
Interventional Trial Phase
Phase 30
Participating Facility
Official Name
An Open-Label, Multi-Center, Randomized, Phase 3b Study to Evaluate the Safety and Tolerability of Switching to One of Two Dosing Strategies of ITCA 650 in Patients With Type 2 Diabetes Receiving Stable Doses of Liraglutide0
Last Updated
November 5, 2018
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
None (Open Label)0
Study summary
A Phase 3b, open-label, randomized, multicenter, safety and tolerability study of ITCA 650 in subjects with Type 2 diabetes taking liraglutide and metformin.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
